Morgan Stanley analyst Eric Serotta lowered the firm's price target on Molson Coors to $46 from $52 and keeps an Equal Weight rating on the shares post a Q1 EPS beat, citing continued structural alcohol headwinds and increased macro and cost risk in FY26-FY27 that the firm views as reflected in the stock's low valuation.
